Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Astrazeneca plc crawled date : 2022 - 11 - 28 save search
Acute Ischemic Stroke Therapeutics Market: Growth Opportunities led by Athersys Inc. and Bayer AG - Technavio
Published: 2022-11-28 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.36%
H: 0.16%
C: 0.16%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -1.93%
H: 0.0%
C: 0.0%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: 0.1%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.14%
C: -0.52%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
BIIB | $201.91 4.52% 4.32% 3.2M
|
Health Technology
|
| O: -0.27%
H: 0.99%
C: 0.11%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.21%
H: 0.16%
C: -0.41%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -0.49%
stroke therapeutics growth
Global Immuno-oncology Market Report to 2028: An Increase in the Research and Development in Cancer Immunotherapy Will Be Driving Growth
Published: 2022-11-28 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -2.51%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.38%
H: 1.09%
C: 0.87%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: -0.68%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.29%
H: 0.45%
C: -0.32%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.65%
H: 0.83%
C: -0.03%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.49%
H: 1.67%
C: 0.64%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: -0.06%
research global immunotherapy report cancer growth market
C4X Discovery Holdings plc: C4XD signs exclusive global licence worth up to $402 million¹ with AstraZeneca for the development and commercialisation of NRF2 Activator programme
Published: 2022-11-28 (Crawled : 08:00) - globenewswire.com
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: -0.06%
global
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.